It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Emerging studies indicate that extracellular vesicles (EVs) and their inner circular RNAs (circRNAs), play key roles in the gene regulatory network and cardiovascular repair. However, our understanding of EV-derived circRNAs in cardiac remodeling after myocardial infarction (MI) remains limited. Here we show that the level of circCEBPZOS is downregulated in serum EVs of patients with the adverse cardiac remodeling compared with those without post-MI remodeling or normal subjects. Loss-of-function approaches in vitro establish that circCEBPZOS robustly promote angiogenesis. Overexpression of circCEBPZOS in mice attenuates MI-induced left ventricular dysfunction, accompanied by a larger functional capillary network at the border zone. Further exploration of the downstream target gene indicates that circCEBPZOS acts as a competing endogenous RNA by directly binding to miR-1178-3p and thereby inducing transcription of its target gene phosphoinositide-dependent kinase-1 (PDPK1). Together, our results reveal that circCEBPZOS attenuates detrimental post-MI remodeling via the miR-1178-3p/PDPK1 axis, which facilitates revascularization, ultimately improving the cardiac function.
The circular RNA circCEBPZOS, present in extracellular vesicles, promotes revascularization and alleviates postinfarct cardiac remodeling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685); Guangdong Provincial Hospital of Chinese Medicine, Department of Critical Care Medicine, Guangzhou, China (GRID:grid.413402.0) (ISNI:0000 0004 6068 0570)
2 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685)
3 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685); Guangdong Provincial Hospital of Chinese Medicine, Department of Critical Care Medicine, Guangzhou, China (GRID:grid.413402.0) (ISNI:0000 0004 6068 0570); Guangdong Provincial Branch of National Clinical Research Centre for Chinese Medicine Cardiology, Guangzhou, China (GRID:grid.413402.0)
4 Division of Cardiovascular Medicine, Stanford University School of Medicine, Department of Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
5 Hospital for Sick Children, Translational Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
6 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685); Guangdong Provincial Hospital of Chinese Medicine, Department of Critical Care Medicine, Guangzhou, China (GRID:grid.413402.0) (ISNI:0000 0004 6068 0570); Guangdong Provincial Branch of National Clinical Research Centre for Chinese Medicine Cardiology, Guangzhou, China (GRID:grid.413402.0); Division of Cardiovascular Medicine, Stanford University School of Medicine, Department of Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)